CRP and COVID-19: Our data support CRP, a proinflammatory factor implicated in intermittent hypoxia pathways and COVID-19 pathophysiology,38,39 as a significant mediator of sleep-related hypoxia and COVID-19 morbidity and mortality, suggesting its role as a relevant intermediary mechanism.